Stocks end mixed as investors assess Gilead coronavirus drug

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

Stocks trimmed or erased early gains in a choppy trading session Thursday to post a mixed finish.

Stocks lost ground after a news report said that an experimental treatment for COVID-19 delivered disappointing results in a trial. The maker of the treatment, Gilead Sciences Inc.

subsequently said the trial results for remdesivir were"inconclusive." The Dow Jones Industrial Average DJIA, +0.16% rose around 39 points, or 0.2%, to end near 23,515, according to preliminary figures, while the S&P 500 SPX, -0.05% lost around 1.5 points, or 0.1%, to end near 2,798. The Nasdaq Composite COMP, -0.00% fell less than 0.1% to end near 8,495. Gilead Sciences shares fell 4.3%.

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 3. in FR

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Stocks close flat after wild session as investors assess Gilead coronavirus treatmentStocks were taken for a wild ride on Thursday that showed how important finding a Covid-19 treatment is for Wall Street. Here's how the major averages performed: - The Dow rose 39 points. - The S&P 500 lost .05%. - The Nasdaq fell .01%. Millions unemployed Profits falling Lying madman is POTUS Markets rising 🙄 Your corporate masters are pleased dimwit investors. Keep ignoring facts and the historic numbers that continue to come out. Infinite bull market!
La source: CNBC - 🏆 12. / 72 Lire la suite »

US stocks close mixed as virus drug report offsets oil-market surge - Business InsiderThe S&P 500 closed negative after a report showing Gilead's coronavirus vaccine failed to benefit patients in a key trial. So a report from the WHO, that covered up for China and has an axe to grind with America for being defunded. Based on a study done in China, who released this virus and lied about it killing thousands of Americans . That is what disrupts a market rally? REALLY . Unbelievable.
La source: BusinessInsider - 🏆 729. / 51 Lire la suite »

These stocks millennials are investing in are 'very good for speculation,' Jim Cramer saysThe top stock picks on the Robinhood trading app for March is a 'fantastic list' for younger investors, the 'Mad Money' host said. Stocks? Gross. Just buy bitcoin.
La source: CNBC - 🏆 12. / 72 Lire la suite »

Stocks making the biggest moves after hours: Snap, Netflix, Texas Instruments and moreStocks making the biggest moves after hours: Snap, Netflix, Chipotle and more
La source: CNBC - 🏆 12. / 72 Lire la suite »